An attack on leading aluminium toxicity expert Christopher Exley in the Sunday Times yesterday begins with the false claim in the title that his funding has been halted. This seems like a blatant attempt to mislead: what was halted the week before last after political pressure was a Go Fund Me page for supporting his research, while the Keele University website has remained open for donations. Another false claim is that there were no controls for his autism brain study. While there were no "normal" brains in the study there were comparisons:
"The aluminium content of brain tissues from donors with a diagnosis of ASD was extremely high (Table 1). While there was significant inter-tissue, inter-lobe and inter-subject variability the mean aluminium content for each lobe across all 5 individuals was towards the higher end of all previous (historical) measurements of brain aluminium content, including iatrogenic disorders such as dialysis encephalopathy , , , , , . All 4 male donors had significantly higher concentrations of brain aluminium than the single female donor. We recorded some of the highest values for brain aluminium content ever measured in healthy or diseased tissues in these male ASD donors including values of 17.10, 18.57 and 22.11 μg/g dry wt. (Table 1). What discriminates these data from other analyses of brain aluminium in other diseases is the age of the ASD donors. Why, for example would a 15 year old boy have such a high content of aluminium in their brain tissues? There are no comparative data in the scientific literature, the closest being similarly high data for a 42 year old male with familial Alzheimer’s disease (fAD) ."
The professional attack in the report is led by Andrew Pollard who is said to be a professor of "paediatric infection": it does not mention Pollard's manifold roles as leader of Oxford Vaccine Group, which develops vaccines with the industry (mostly containing aluminium), as chair of the Joint Committee on Vaccination and Immunisation which recommends vaccines to the British schedule, as leading adviser to the British and European licensing agencies, and board member of the Jenner Vaccine Foundation. In July 2017 he also called in the Guardian newspaper for compulsory vaccination without disclosing any of these roles. Real investigative journalists might be asking what research Pollard has ever undertaken into the safety of aluminium adjuvants in vaccine products which he helps develop, recommend and license?
John Stone is British editor of Age of Autism